source
- Intellia's in vivo CRISPR therapy first to succeed in Phase 3An experimental treatment that uses CRISPR to edit genes directly inside the body has just succeeded in a Phase 3 trial — a first for the technology — putting it on track for a potential FDA approv…Endpoints · 3mo ago↗ source
- STAT+: Intellia says CRISPR-based treatment for rare disease reduced swelling attacks in pivotal trialWith good results from Intellia, the CRISPR field faces the question: How attractive will the one-and-done approach be to patients and doctors?STAT · 3mo ago↗ source
- Veradermics wins at growing hair with oral Rogaine in first key test as a public companyVeradermics has succeeded in its first major test as a newly-minted public company. The biotech's form of oral Rogaine cleared the bar in a Phase 2/3 trial in men with mild-to-moderate pattern hair…